1 / 33

Towards an Integrated Research Policy in the Area of Drug Discovery in the Arab Countries

Towards an Integrated Research Policy in the Area of Drug Discovery in the Arab Countries Including mechanisms to better utilization of their terrestrial and marine wealth . Bassem El-Menshawi NEPAD Sci & Technol Regional Coordinator for Northern Africa,

hillary-goff
Download Presentation

Towards an Integrated Research Policy in the Area of Drug Discovery in the Arab Countries

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Towards an Integrated Research Policy in the Area of Drug Discovery in the Arab Countries Including mechanisms to better utilization of their terrestrial and marine wealth. Bassem El-Menshawi NEPAD Sci & Technol Regional Coordinator for Northern Africa, National Research Centre, Cairo, Egypt

  2. DRUG DISCOVERY TYPES OF RESEARCH LABORATORIES NEEDED: This depends on the therapeutic class required

  3. DRUGS TO BE DISCOVERED FOR EXAMPLE: IF PRIORITY GIVEN TO: -ANTITUMORS, -ANTICARCINOGENIC, -IMMUNOMODULATORY, -ANTIVIRAL AGENTS A CELL CULTURE LAB IS NEEDED

  4. THE STATE OF THE ART OF DRUG DISCOVERY: • THE USE OF IN VITRO BIOASSAYS • THE USE OF CELL LINES (e.g. HUMAN TUMOR CELL LINES) ADVANTAGES AND DISADVANTAGESIn-Vitro Bioassays-Rapid, less selective, but diagnostic, less expensive, -suitable for minute amounts of materials, -suitable for screening large number of samples in Drug Discovery programs.In-Vivo Bioassays More selective, expensive, mostly Time Consuming,Animal model, require large amounts of material,hardly could guide the fractionation of extracts or mixture of compounds.

  5. TYPES OF RESOURCES TO BE UTILIZED: Natural Resources Line : - Plants - Microbes (bacteria, fungi) - Marine Organisms Synthetic Line: - Novel Chemical Entities - Generics

  6. THE BASIC CHEMICAL LABS: LAB FOR NATURAL PRODUCTS (Isolation of Natural Compounds) LAB FOR SYNTHESIS (Rational Pharmacological, & Computer Aided Drug Design)

  7. IN ADDITION TO - ANTI-VIRAL TESTING LAB - PHARMACOLOGICAL PROFILE & TOXICOLOGY LAB

  8. FOR BIOTECHNOLOGICAL PRODUCTS A BIOTECH / MOLECULAR BIOLOGY FOR DISCOVERY OF ANTIBIOTICS: AMICROBIOLOGY / FERMENTATION LAB FOR ANTI-SCHISTOSOMIASIS: PARASITOLOGY LAB

  9. THERAPEUTIC NATURAL PRODUCTS - ACTIVE COMPOUNDS - ACTIVE EXTRACTS - COMBINED ACTIVE EXTRACTS

  10. METHODS OF DRUG DISCOVERY FROM NATURAL PRODUCTSHow the Active Principle be identified ? -Phytochemical Approach -Bio-Activity Approach -High Throughput Screening -Computer Aided HPLC/MS

  11. EXISTING PROJECT MODEL: AT THE NATIONAL RESEARCH CENTRE, EGYPT A SEARCH FOR SCHISTOSOOMICIDAL, ANTITUMOR, ANTICARCINOGENIC, IMMUNOMODULATORY, AND ANTIVIRAL AGENTS IN EGYPTIAN PLANTS

  12. This is a drugdiscovery program conducted at NRC • based on Egyptian plants, • utilizes universally accepted protocols for bioactivity-guided fractionation of plant extracts, • and in-Vitro Bioassays.

  13. Under this project Egyptian plants are Bio-assayed for specific medicinal activities: • Schistosomicidal • Antitumor • Cancer chemopreventive [anticarcinogenic] • Immunomodulating • Antiviral

  14. BIOACTIVITY APPROACH:-Extracts are screened for a specific medicinal activity (an in-vitro bioassay).-Only BioActive extracts are fractionated.-Active fractions are further fractionated to isolate the active compound(s) in pure form. -Characterization of its structure.

  15. Only Bio-Active Extracts are subjected to Bioassay-Guided Fractionation, in 2 steps: • Initial Partitioning • Comprehensive Fractionation for the isolation of their active principles.

  16. EX-VIVO BIOASSAY • In-Vivo / In-Vitro • Used for assaying the activity of compounds isolated in limited amounts, • untill additional materials could be obtained sufficient for in-vivo bioassy. • It detects the effect of in-vivo absorption and metabolism on compounds that are active in-vitro.

  17. Active compounds isolated are then bioassayed in animal models to confirm the bioactivity and determine theirtherapeutic value and toxicity profiles.

  18. The overall accomplishments After 3 years of the project’s life are as follows:

  19. Conclusions-Screening Large Number of Natural Species-Using In Vitro Bioassays-For 5-10 Medicinal Activities

  20. Conclusions:-Integrates Arab Natural wealth-Optimizes Arab IPR-Enhance the Invention in a Strategic Area

  21. Conclusions- 1-3 Central Joint Research Lab (under one strategy, one mechanism, one protocol, and one leader).- Nodes in each country- Joint Surveying of Biodiversity-Joint Ownership of Products- Networking

  22. Conclusions- Arab Meeting for Strategic Planning of Drug Discovery- Role of Bibliotheca Alexandrina

  23. ALL THE PRAISES AND THANKS BE TOALLAH

  24. THIS PROJECT IS FUNDED BY THE ACADEMY OF SCIENTIFIC RESEARCH AND TECHNOLOGY, CAIRO, EGYPT, UNDER THE PROGRAM OF BIOTECHNOLOGY 1998.

More Related